Coping with the forced swim stressor: Current state-of-the-art by Molendijk, M.L. & De, Kloet E.R.
Contents lists available at ScienceDirect
Behavioural Brain Research
journal homepage: www.elsevier.com/locate/bbr
Invited review
Coping with the forced swim stressor: Current state-of-the-art
Marc L. Molendijka,⁎, E. Ronald de Kloetb
a Institute of Psychology, Leiden University and Leiden Institute for Brain and Cognition, Leiden University Medical Center, Leiden, the Netherlands
bDepartment of Endocrinology and Metabolic Disease, Leiden University Medical Center, Leiden, the Netherlands
A R T I C L E I N F O
This article is dedicated to Dirk Hellhammer (†
december 1, 2018) a pioneer in psycho-
endocrine research, who has left a legacy in the
Trier Social Stress Test and Neuropattern™
Keywords:
Porsolt forced swim test
Stress
Depression
Prefrontal cortex
Glucocorticoids
A B S T R A C T
The forced swim test (FST) for rodents does not model despair or helplessness. It also is not a read-out for
depression, anxiety, psychomotor retardation or autism, because these are anthropomorphic interpretations of
the rodent’s acquired immobility. Rather, the transition from swimming to immobility allows to examine the
mechanistic underpinning of coping with inescapable stressors. However, in a recent detailed analysis of the FST
application over the past 40 years, we noted a dramatic surge in the use of this test to phenotype animals as
‘depressed’. As a follow up to that report, we now present an analysis of the use of the FST over the past three
years. This literature analysis shows that the popularity of the FST is still increasing and that the majority of
researchers qualifies the rodent’s floating response as depressive-like behavior. However, over the past few years
we also note a trend to interpret immobility rather as the expression of a coping strategy. In view of this result,
we have sent a poll to the relevant authors to learn how consistent they are in naming FST behavior.
Remarkably, we find a dramatic inverse correlation between their first qualification of acquired immobility as
depressive-like behavior towards their current interpretation as coping strategy. In this contribution we have
embedded our literature analysis and poll results in an update on the management of coping with inescapable
stressors by processing in prefrontal cortical circuitry and glucocorticoid feedback.
‘Two little mice fell in a bucket of cream. The first mouse quickly gave up
and drowned. The second mouse wouldn’t quit. He struggled so hard that
eventually he turned that cream into butter and crawled out.’
Frank Abagnale Sr. and Jr., from the moving picture Catch me if you
can (2002).
1. Introduction
About 40 years ago the forced swim test was designed for rapid
screening of compounds with potential antidepressant activity [1]. Al-
though this test was considered at that time very effective, one may
conclude today that its predictive validity is disappointing, since it has
not delivered novel antidepressants. The FST also does not have face
and construct validity, because there is no single aspect modeled of
depression, and the observed behavior is a ‘dependent variable of the
test situation itself’ [2]. Rather, learning to become immobile in the FST
may serve as model to examine the mechanistic underpinning of the
coping strategy used by the rodent to achieve behavioral adaptation to
inescapable stressors [3–5]. Accordingly, the action mechanism of
glucocorticoids and dopamine in processing the acquired immobility
response during coping with the forced swim stressor has been
thoroughly investigated [6–8].
Three years ago we reported that about 4300 FST papers had been
published and that half of them had used the test to phenotype ge-
netically modified animals with or without a history of stress [3,4]. We
also noted that anno 2015 one FST paper per day appeared and that
labeling immobility as a depressive phenotype had become common
practice. Since we are interested in changes in interpretation of FST
behavior, we have examined the literature on the use of this test over
the past three years. We also have sent a poll to the relevant authors
who use or have used this test in order to learn their opinion on the
interpretation of the FST data. In this contribution we will first present
the results from our literature analysis and the outcome of the poll.
Next, these results will be embedded in a state-of-the-art review of the
science of coping with inescapable stressors. We will discuss the phe-
notypes identified with the forced swim and address management of
stress-coping from prefrontal cortical control to glucocorticoid feed-
back.
2. Major depression
With a one-year prevalence of about 7 percent in developed coun-
tries [9,10], major depression is a common illness (See Box 1 for the
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depression symptoms [11]. Whether a symptom is present is indicated
verbally by the patient, or in some cases based on the impression of a
clinician [11]. The World Health Organization [12] states that de-
pression is one of the leading causes of disease burden worldwide, as-
sociated with morbidity [13,14], and due to its relatively high suicide
rates [15], also with mortality [16].
Box 1: The diagnostic criteria for major depressive disorder (APA
2013) [11].
Depression may be diagnosed if 5 (or more) of the following symptoms have been
present
during the same 2-week period and represent a change from previous functioning.
At least
one of the symptoms is either (1) or (2)
1 Depressed mood most of the day, nearly every day, as indicated by either
subjective report or observation made by others. In children and adolescents,
this can be irritable mood
2 Markedly diminished interest or pleasure in (almost) all, activities most of the
day, nearly every day (as indicated by either subjective account or observa-
tion made by others)
3 Significant weight loss when not dieting or weight gain (e.g., a change of more
than 5% of body weight in a month), or decrease or increase in appetite nearly
every day
4 Insomnia or hypersomnia nearly every day
5 Psychomotor agitation or retardation nearly every day (observable by others,
not merely subjective feelings of restlessness or being slowed down)
6 Fatigue or loss of energy nearly every day
7 Feelings of worthlessness or excessive or inappropriate guilt nearly every day
(not merely self-reproach or guilt about being sick)
8 Diminished ability to think or concentrate, or indecisiveness, nearly every day
9 Recurrent thoughts of death, or a suicide attempt or a specific plan for
committing suicide
B. The symptoms do not meet criteria for manic features in the presence or the past
C. The symptoms cause significant distress or impairment in important areas of
functioning
D. The symptoms are not due to direct physiological effects of a substance/medical
condition
E. The symptoms are not due to mood-incongruent delusions or hallucinations
The symptoms of depression are heterogeneous and descriptive and
they do not provide an etiological model of the illness. Current research
suggests that predisposing genetic factors and (early) life events play a
key role in the etiology of depression [11,17] along with an altered
responsiveness of the stress system [18,19], cognitive malfunctioning
[20] and disturbances in neurotransmitter- [21], neuropeptide [22],
and neurotrophic systems [23–25]. The common pharmacological- and
psychological treatments of depression are at best modestly effective
and about one third of the patients is therapy resistant [26,27]. This is
in part due to the heterogeneous presentation of depression [28], which
complicates the selection of the best possible treatment strategy.
Moreover, progress is also hampered by the incomplete knowledge of
the mechanism the treatment should target.
A major goal of current research is to reach out beyond a descriptive
notion of major depression and to move to a model of this mental illness
that takes the etiological mechanism into account [17]. For this purpose
the Research Domain Criteria (RDoc) have been formulated by the
National Institute of Mental Health in 2018: https://www.nimh.nih.
gov/research-priorities/rdoc/definitions-of-the-rdoc-domains-and-
constructs.shtml#part_154187. The RDoc strategy concerns the in-
tegration over different levels (units of analysis) of biological complexity
- from genome to circuits, behavior and self-reports-, which will pro-
duce criteria that may help translation of psychological constructs to
domains of human behavior. Obviously, stress hormone action on coping
and adaptation is fundamental for this approach [22,29]. As noted by
Bruce McEwen [30]: “cortisol acts in 6 RDoc units of analyses from
gene to behavior; the hormone can alter arousal and regulatory cir-
cuitry and affects psychosocial, cognitive, positive- and negative va-
lence systems. Accordingly, it seems therefore that the RDoc framework
does not yet fully recognize the role of stress and stress hormones in
coordinating the domains over the various units of analysis in neu-
roendocrine, immune and metabolic interactions.”
Van Praag introduced many years ago the concepts of functionali-
zation and verticalization (prioritizing psychic dysfunctions) in psychia-
tric diagnosis. Functionalization of diagnosis refers to a ‘conglomerate of
interacting dysfunctions, within the psychic apparatus in the provinces of
affectivity, cognition and motor regulation’. In this way anxiety / aggres-
sion-driven depression was identified as a possible subtype of depres-
sion [31]. Another innovation was pioneered by the late Dirk Hell-
hammer using an approach entitled Neuropattern™. These are patterns
(conceptual endophenotypes) of co-occuring neuroendocrine, biolo-
gical, psychological and symptomatic features that signal striking
changes in the activity and reactivity of brain circuits involved in
coping with stress and which are defunct in stress-related psychiatric
disorders such as depression. This approach can provide at least 13
distinct individual-specific patterns which can be used for rational
personalised psycho- and neuropharmaceutical therapy recommenda-
tions [32].
In view of these considerations the development of valid animal models
for the study of vulnerability to these various dysfunctions in depression will
be indispensable. Although it is obvious that the forced swim test (FST) is
not a model for depression, the FST may provide an opportunity for study of
the mechanism underlying coping with inescapable stressors, which -if
persisting- may enhance vulnerability to depression.
3. The forced swim test
The FST was presented first by Roger Porsolt and his colleagues [1]
as an animal behavioral model that resembles depressive illness and that
is selectively sensitive to clinically effective antidepressant treatments (page
730). Box 2 provides a description of this test. For more detailed in-
formation on FST protocols, we refer to the publications by Porsolt
[1,33] and Cryan et al [34].
About three years ago we have presented a detailed analysis of the
use of the FST over the past 40 years [3]. We found an increase in the
use of the FST over the years. More importantly we noted a dramatic
surge in the proportion of papers in which the FST was used to label
animals as being depressed. This is surprising, because the FST lacks
face and construct validity to assess depression or depressive-like be-
havior.
Box 2
A description of the FST. Adapted from De Kloet and Molendijk [4].
In the original version of the FST, a rodent is placed in a beaker (width:> 20 cm; depth ∼15–18
cm) filled with water of 24 ± 2 degrees ∘C from where escape is not possible. The rodent is let to swim for 15minutes. After the session,
the animal is removed from the water, dried, and placed back in the home cage. Twenty-four hours later, the rodent again is placed in the
beaker. During this second swim experience, that usually lasts 5 or 6minutes, most animals start showing passive behavior soon. When this
occurs, the animal is said to be immobile or that it floats. The time from placement in the cylinder to immobility / floating, is regarded as the
main outcome measure of the FST experiment. Over the years, the original version of the FST has undergone some modifications. A major
modification is the use of the test to measure immobility in a single session, thus without the 15minutes pretest, in particular for mice.
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Porsolt already noted that the immobility response in the FST is the
‘dependent variable of the test situation itself’ [2]. Moreover, the response
to the FST is instantaneously, while the pathogenesis of depression
extends over weeks or months. Furthermore, the animal’s transition to
floating is said to demonstrate despair as a consequence of learned
helplessness, but these are no major symptoms of the depressive phe-
notype either. Other proposals labeled the animal’s behavior as psy-
chomotor retardation [33,35] or anxiety [36], but these opinions are
also not supported by scientific facts. Commons et al. [5] demonstrated
that the animal’s response to FST could easily be interpreted also as
autism like-behavior and substance abuse.
In our previous reports [3,4], we arrived at the conclusion that the
FST presents a unique paradigm to investigate the mechanistic under-
pinning of ‘coping with an acute inescapable stressor’. If the situation is
appraised as inescapable the rodent will acquire immobility after initial
attempts to escape by swimming, struggling and climbing. This switch
from an active to passive coping style favors energy conservation until a
new option to escape is presented. In the original version of the FST the
immobile animal is saved by the experimenter after the 15min initial
test and the animal learns that remaining immobile is associated with a
survival option. It was shown 30 years ago that the consolidation of this
acquired immobility response was disrupted by glucocorticoid antago-
nists, opioid antagonists and various types of antidepressants
[37–39,4].
4. Use and interpretation of the FST from June 2015 to June 2018
In 2015 we published a rapport on the use of the FST and the in-
terpretation of the results derived from this test [3]. In this rapport we
show that the FST attained ever increasing popularity and that a
growing proportion of papers labels the observed immobility as de-
pression-like behavior. Here we update this rapport and investigate
potential changes in the interpretation of the behavior that can be ob-
served in the FST from 2015 onwards.
Between June 2015 and June 2018, about 2100 papers have been
published that reported the use of the FST. This estimate is based on a
PUBMED search (final search date 22-08-2018) using the search terms
Porsolt swim test OR forced swim test. We find that the yearly number
of papers that report on the use of the FST increased from June 2015 to
June 2018 from about 430 in 2015 to about 600 in 2018. This is in line
with the trend that we observed earlier [3].
We took a random sample of 285 papers (18%) from all FST-papers
published between June 2015 and June 2018. Sample size of this
random selection was chosen in order to provide a representative
overview [40]. We estimate from this sample that in 71.9% of the pa-
pers, the FST is used to score depression-like behavior, while in about
19.1% the FST was used to infer on the anti-depressant-like properties
of certain compounds or procedures. In the remaining 9.0% of the pa-
pers, the FST was used to stress the animal (3.2%), or to assess its
coping capacities (2.1%), endurance or fitness (1.8%), or learning ca-
pacities (0.4%). In 0.7% of the papers, the FST was used as a read-out
for immobility, without further connotation.
The interpretation of the behavior observed in the FST changed
from June 2015 to June 2018. Authors tended to interpret the floating
behavior increasingly less often as representing depression-like beha-
vior (Spearman’s rho (ρ) = -.24, 95% CI = -.39 to -.08, P < .01) while
the use of alternative interpretations increased over time (ρ= .55, 95%
CI= .43 to .67, P < .0001). This was particularly due to an increased
tendency to use the FST as a read out for coping behavior (ρ = .76, 95%
CI= .68 to .84, P < .0001). No change was observed in the propor-
tion of papers that scored an antidepressant response using the FST (ρ
= .09, 95% CI = -.07 to .27, P= .26).
The interpretation of FST results not only changed from June 2015
to June 2018 but also relative to a prior period of equal length; from
June 2012 to June 2018. We find that a smaller proportion of FST
papers in which the observed behavior was labeled as depression-like
behavior in the years 2015–2018 relative to the years 2012–2015. The
inference that behavior in the FST reflects a response to an anti-de-
pressant increased over the time-frame 2015 - June relative to the
downward trend observed in the time frame prior to that. Alternative
interpretations of the observed behavior (e.g., as coping) also were used
increasingly more often in recent-, relative to earlier years. For esti-
mates of the strength of these associations and the statistical sig-
nificance of their differences we refer to the Table 1.
5. A poll on (changes in) FST interpretations
We wanted to know whether the above presented changes in in-
terpretations of FST results also were evident in the opinion of re-
searchers. This was investigated by means of a non-random poll among
researchers who use or have used the FST and who have been citing our
work [3,4].
Through PUBMED, Web of Science and Google scholar we identified
articles that cited one of our papers on the FST [3,4]. The total number
of citations to these articles was 159. After deletion of duplicate cita-
tions and reading title and abstract of these papers to ascertain elig-
ibility, we discarded 75 records. Among the discarded records were for
instance reviews or studies on humans that did not report the primary
use of the FST. We extracted the email addresses of the corresponding
and/or senior authors of the remaining 84 articles, and we sent them an
email in which we asked them the following:
1 Since when are you using the FST?
2 How many papers have you published in which the FST was used?
3 How did you initially interpret FST results?
4 How do you in your current or latest research interpret FST results?
5 Were there comments from reviewers on the chosen interpretation
of the FST results?
Fifty-two percent (n=44) of the authors, to whom we sent out the
poll, responded. There was a wide variety with regard to the experience
these authors had with the FST (range number of papers published in
which the FST was used=1–40 papers [average=6]). Some of them
published their first paper using the FST in 1982, others in 2017.
Seventeen (39%) of the authors mentioned to have received reviewer
comments on their interpretation of the FST.
Overall the authors reported differences in interpretation of the
behavior from first- to current/latest use (χ225= 51.5, P < 0.01). The
Table 1
Changes over time in the interpretation of behavior observed in the FST: data for June 2012 - June 2015 and June 2015 - June 2018.
2012–2015 (N=97) 2015–2018 (N=285) Difference (interaction)a
Antidepressant response ρ = -.65*** ρ = .10 ***
Depressive-like behavior ρ = .66*** ρ = -.24*** ***
Otherb ρ = -.12 ρ = .55*** **
** statistically significant at P < .01, *** statistically significant at P < .001.
a The interaction effects, indicating change in interpretation over the two time-frames, were also significant when we compared the time-frames June 2012 vs.
June 2015 vs.1978–2015.
b The category other includes the following interpretations: stressor, anxiety, immobility (without further connotation), and mixed interpretations.
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observed and significant differences were in line with what we observed
in the survey of the literature: more and more authors stated to inter-
pret immobility as for instance coping or acquired immobility and
fewer as depression-like behavior or something related to this (e.g.,
despair). Details from our poll can be found in Table 2.
The results from this poll and the survey of the literature, together
show the dynamic nature of how immobility, as observed in the FST, is
interpreted. Currently the trend is such that it is increasingly less often
labeled as depression–like behavior.
A limitation that is worth mentioning here is that social desirability
bias cannot be excluded as the driving force underlying the pattern of
results derived from our poll. Self-reported data was used after all and
the authors who were approached probably knew our stance with re-
gard to the questions that we asked them [41].
6. Coping with stressors
Here we will review in the next sections the progress in under-
standing stress-coping with reference to the FST. We first discuss the
phenotype of rodents displaying either an active or a passive behavioral
response to the inescapable stressor. Then, the implication of brain
circuitry, dopamine and the glucocorticoid stress hormone in manage-
ment of stress-coping is examined.
6.1. Stress-coping phenotypes
Henry and Stephens defined the active fight-flight and the passive
conservation withdrawal mode as two evolutionary successful coping
strategies [42]. In line with this concept Koolhaas et al. [43] identified
highly aggressive short attack latency (SAL) mice as pro-active rather
than active copers because of their tendency to take the initiative in
fights vs the reactive (passive) copers that actually had a lower threshold
to ‘freeze’ during such violent confrontations. In their analysis the
Koolhaas lab extensively phenotyped the animals with the two opposite
coping styles. Among numerous other parameters, pro-active coping is
characterized by high sympathetic activity and low stress-induced
glucocorticoid secretion with a pro-inflammatory and auto-immune
bias, while the re-active (passive) ones show the opposite pattern where
parasympathetic activity is prominent with high glucocorticoid secre-
tion [44,45]. This led Mechiel Korte to distinguish these two divergent
rodent phenotypes prosaic as Hawks vs Doves [46].
Other researchers have examined extensively rats that are rapid
learners of shuttle box active avoidance behavior i.e. Roman High
Avoidance (RHA), in comparison with Roman Low Avoidance (RLA),
which learn slow and display a more passive (freezing) response [47].
The RLA line shows much higher emotionality than RHA’s. The latter
RHA rats display little anxiety in a novel environment, express novelty-
seeking and increased impulsivity, but surprising are less aggressive
[48,49]. As is the case with the SAL mouse line, male rats of the pro-
active behaving RHA line actively cope with the non-escapable swim
stressor, while the reactive (passive) RLA rats show the passive coping
style, particularly in the retest [47]. RHA animals are resistant to anti-
depressants in the FST and show much less FST-induced HPA-axis
activity and lower prolactin release than their RLA counterparts
[48,47,50]. HPA axis activity associated with FST behavior was ex-
tensively investigated in five different rat strains by Armario et al.
[51,52]. These experiments identified alike the RLA’s, the Wistar Kyoto
strain (rather than spontaneous hypertensive rats) as the strain pre-
disposed for passive coping.
The FST has also been used to pre-select animals for their coping
performance as criterion to test their vulnerability to subsequent
stressors. One recently published example by Mul et al [53] is based on
exposure to the FST for 5 consecutive days when all mice were found to
show a passive coping style; this repeated FST procedure did not pro-
duce dysregulation of emotional, homeostatic or psychomotor func-
tions, however. In a variation of this approach by Wislowska-Stanek
et al. [54], rats were divided according to their immobility times after
first exposure to the FST. The passive copers appeared more vulnerable
to challenges related to the function of the VTA dopamine system,
which includes exposure to social isolation or a restraint stressor. This
phenotype was associated with increased dopamine turnover and re-
lease in the VTA – amygdala terminal area, where also increased ex-
pression of cocaine- and amphetamine (CART) related peptide was
found.
In conclusion, the distinction in active and passive coping styles
observed in the FST represents two very different phenotypes, which
are labeled in their response pattern to psychosocial stressors as pro-
active and reactive, respectively. The two distinct phenotypes can be
predicted by genetic factors and are associated with widely divergent
patterns of e.g. stress-induced HPA-axis and autonomous activity, pro-
lactin release and dopamine signaling. Accordingly, the FST procedure
can be used to rapidly select animals with an extreme different phe-
notype for further study of stress vulnerability and resilience.
6.2. Stress-coping management
Mice of the DBA2 vs C57Bl6 inbred strains also showed large dif-
ferences in active vs passive coping with the inescapable stressor en-
countered in the FST [55]. This difference was demonstrated in the
initial tests as well as at retest 24 h later. In their pioneering research,
the Cabib lab reported that the passive C57Bl6 mice showed swim-ac-
tivation of the amygdala - hippocampal circuitry by using c-fos ex-
pression as marker. The actively coping DBA’s were found to rely
heavily on an amygdala - dorso-lateral striatal (DLS) dopaminergic
mechanism, which is also prominent in stereotypical, habit and ad-
dictive behavior [56,55,8]. The effects that were visualized by c-fos
expression, show a profound lateralization, though, and the changes are
most prominent in the left DLS. Interestingly, lesioning of the left DLS
or local treatment with D2 antagonists abolishes retention of the ac-
quired immobility in the DBA’s, while hippocampal lesions interfere
with memory performance of the C57 Bl6 mice [55]. In addition,
downregulation of left DLS-D2 receptors by previous food deprivation
also interferes with memory consolidation c.q. retention of acquired
immobility [56].
It is generally thought that the ventromedial prefrontal cortex
(mPFC) is central to top-down control of stress-coping because of its
Table 2
Poll results. Percentage of use and 95% Confidence Interval (CI) for each interpretation of the behavior observed in the FST by first vs. current or latest use.
First use % (95% CI) Latest use % (95% CI) Z-valuea
Antidepressant response 9.8 (2.0 – 23.8) 2.4 (0.1–12.8) 1.59
Depressive-like behavior 65.9 (49.5 – 80.0) 12.2 (4.1–26.6) 7.25***
Coping/learning/acquired immobility 14.6 (5.5 – 29.1) 56.1 (39.8–71.5) 7.53***
Otherb 9.8 (2.7 – 23.2) 29.3 (16.5–45.6) 4.20***
*** statistically significant at P < .001.
a We calculated a Z and P-value for the difference between the observed proportion that a given interpretation is used (‘latest use’) vs. the observed proportion a
given interpretation was used (‘first use’).
b The category other includes the following interpretations: stressor, anxiety, immobility (without further connotation), and mixed interpretations.
M.L. Molendijk and E.R. de Kloet Behavioural Brain Research 364 (2019) 1–10
4
function in decision-making, planning and cognitive flexibility.
Depending on the nature, activity and duration of the stressor various
neuronal ensembles in mPFC are recruited in circuits serving executive
behavioral and physiological reactions. Thus, the mPFC projects to
circuitry in the extended amygdala i.e. bed nucleus striae terminalis
(BNST), the various amygdala nuclei and parts of the striatum, hy-
pothalamic and thalamic nodes and connects via these hubs to neu-
roendocrine, autonomic and behavioral output pathways in the para-
ventricular nucleus (PVN) and peri-aquaductal grey (PAG). Simona
Cabib et al. pointed out that the passive coping response to un-
controllable stress evolved upon the switch from prelimbic-mPFC (pl-
PFC) regulating goal-directed towards stimulus-response behavior by
the infralimbic (il)-PFC – DLS circuit [8].
Radley and coworkers distinguished more than 10 years ago the role
of the il- and pl-PFC during emotional stress in control of PVN function
by placing discrete lesions in these areas. Briefly, they found that the pl-
PFC primarily regulated HPA axis activity by inhibiting the neu-
roendocrine CRH cells in the paraventricular nucleus (PVN), while il-
PFC rather restrained autonomic functions via adjacent PVN cell groups
[57] Pioneering work by the Jim Herman lab [58] have further outlined
some features of the il-PFC projectome. During a chronic (un-
controllable) stressor the glutamatergic mPFC output is attenuated
because of atrophy of the mPFC neurons and an impairment of the
glucocorticoid-dependent break on the inhibitory GABA-ergic control of
excitatory output within the mPFC. Both actions synergize and the re-
sult is a weakened il-PFC excitatory outflow during chronic stress, and
thus suggesting a less restrained autonomic and neuroendocrine stress
reaction [59,60,58].
The PFC input to the avBNST activates GABA-ergic cells that either
innervate the hypothalamic PVN for neuroendocrine control and the
vlPAG for expression of passive coping [61–63]. Lesioning the BNST
advances the onset and increases duration of immobility in the FST
retest [64]. In line with this, Johnson et al [61] reported that inhibition
of the pl-PFC glutamatergic input of the avBNST increased passive
coping in the tail suspension test (stimulation of glutamatergic avBNST
input decreased passive coping). a finding that is in line with the stress-
induced pl-il switch [8]. The finding was confirmed with variations in
the ‘immobility’ response when the rats were exposed to the shock prod
burying test. Actually, the important discovery was made that varia-
tions in activity of the pl-PFC top-down excitatory outflow via the
GABA-ergic avBNST hub was expressed as a variation in ‘gating’ of
passive coping that is mediated via the vl-PAG rather than these ma-
nipulations directly modulate active coping via the dl- and L-PAG.
About 20 years ago Bandler and Keay et al. [65,66] found that ac-
tive coping responses are triggered by electrical or chemical stimulation
of the dorsolateral and lateral columns (dl-PAG and L-PAG). C-fos ac-
tivation of these PAG columns was observed during active coping with
an escapable stressor and was associated with sympathetic activation of
heart rate and pressor responses. In contrast, passive coping was evoked
upon stimulation of the vl-PAG and is characterized by c-fos activation
of this column during either inescapable physical (e.g. pain, tissue da-
mage, hemorrhage) or psychological stressors. Activation of this vl-PAG
pathway causes hypotension and bradycardia as hallmarks of quies-
cence and parasympathetic activation.
The passive coping style represents decreased responsiveness to
environmental stimulation, while quiescence and immobility would
allow for recovery and wound healing. However, Koolhaas and col-
leagues [44] assigned to the passive (in their case reactive) coping
animals a phenotype that is guided by the environment. Such animals
are more successful upon dispersal than the active copers. In contrast,
the active coping trait features an optimal performance if conditions are
predictable in the animal’s own territory. Both views are not necessarily
in contradiction: the Bandler/Keay c.s. view considers performance in
the immediate aftermath of a challenge, while Koolhaas et al. highlights
the performance of animals in psychosocial interactions.
The effect of psychological stressors on the PAG columns suggests
control that is exerted by input from the PFC, hypothalamus and
amygdala [65,66]. Information processing by the mPFC neurons is
modulated by e.g. hippocampal contextual and amygdala-triggered
emotional inputs, while valuation of the nature of the stressor is pro-
cessed by the ventral tegmental area (VTA) striatal pathways. For
modulation from different brain areas the BNST was found to be a
critical node in this pattern of coping with stress [67]. In this respect
confronting the rodent with the FST enhances dopamine release in the
VTA as part of a scenario to control the stressor. Next, when after some
time the animal appraises the situation as uncontrollable, DA release
decreases in parallel with acquiring the passive coping style [68,8].
Chronic exposure to unpredictable stressors indeed reduces VTA-DA
dopaminergic activity and is paralleled by a number of behavioral
features including passive coping in the FST [69,70]. In support, op-
togenetic inhibition of the VTA dopaminergic cells causes immobility in
the FST, while activation had the reverse outcome; the rats attempted to
swim and escape again as part of their active coping repertoire [6].
In contrast, a paradigm of 10 days social defeat activated VTA-DA
neurons [71], but reduced sucrose preference [72,23,73,74]. Interest-
ingly, optogenetic inhibition of the VTA-DA cells in this social defeat
model led to a reversal of this phenotype [75]. Thus, it seems that the
role of VTA-DA in coping is different under conditions of a predictable
(daily immobilization, repeated social defeat) vs an unpredictable
chronic stress experience. Indeed, daily chronic immobilization for 12
days enhanced active behavior, particularly if the last immobilization
was applied shortly before the FST. In these chronically stressed rats, a
higher efficacy of de dopamine antagonist haloperidol was observed in
suppression of active coping behavior. This finding suggests an in-
creased role of dopaminergic transmission in active coping after chronic
daily immobilization stress [76]. Accordingly, ventral and dorsal
striatal pathways communicate via an intra-striatal spiraling cascade
the motivation to act towards the actual motor response. Rat lines se-
lected for a high apomorphine sensitivity indeed show the phenotype of
active coping and stereotypical gnawing linked to the nigrostriatal A9-
DLS projection [77].
The top-down PFC control implicates secretion of the glucocorticoid
end products of the hypothalamus-pituitary-adrenal (HPA) axis, cortisol
and corticosterone, which act via high affinity mineralocorticoid re-
ceptors (MRs) and lower affinity glucocorticoid receptors (GRs) (Box 3).
MR activation during stress favors the selection of non-declarative
(habitual) learning to cope with escapable stressors [78] by prioritizing
the amygdala-DLS pathway at the expense of amygdala-hippocampal
circuit underlying declarative learning [79–81]. An active coping style
in the FST, characteristic for dominant individuals goes along with
highest limbic MR expression, low HPA axis activity and a high sym-
pathetic tone [82]. MR antagonists disinhibit HPA axis activity, reduce
sympathetic tone, are anxiolytic and reduce aggression [83–87].
Blocking the MR interfered with habit learning and re-established the
hippocampal cognitive program back into central stress-coping pro-
gram. Cognitive performance became, however, slower and less effec-
tive after mineralocorticoid antagonist treatment [78–88]. In rodents
the switch in coping style shows a sex difference; females actually
prefer cognitive control rather than habit learning during stress [89].
While the MR activation is prominent during the initial phase of
stress-coping, GRs become only activated with rising glucocorticoid
concentrations and were found to facilitate memory storage of the se-
lected coping response (Fig. 1). Thus, GR antagonists administered right
after the initial 15min FST interfered with memory storage [112,113]
and this action was located in the hippocampal dentate gyrus [39].
Hans Reul and coworkers discovered in a series of elegant experiments
that the facilitation of memory storage in the FST requires synergy with
glutamate transmission. These experiments demonstrated in discrete
neurons of the hippocampal dentate gyrus that not only glucocorticoid
antagonists, but also specific genetic deletions in the underlying sig-
naling pathway (i.e. MSK1/2) could prevent the consolidation of ac-
quired immobility. The data suggest involvement of an epigenetic
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mechanism driven by histone modification, and immediate early gene
activation as hallmarks of chromatine reorganization [114,115,7].
Chronic stress per se did not alter much the hippocampal dentate
gyrus transcriptome, an additional challenge with an acute heterotypic
stressor such as the FST -or even corticosterone itself for that matter
[116,117]- revealed a pronounced difference in genomic organization.
In particular the expression of genes with a role in chromatine re-
organization, epigenetics, inflammatory cytokine pathways and sy-
naptic plasticity was enhanced.
In conclusion, pioneering studies that combine optogenetic with
tracing techniques have demonstrated the connectivity of the mPFC
with downstream nodes that activate autonomic, neuroendocrine and
behavioral output. Future studies will undoubtedly further unravel how
the nature, duration and chronicity of a perceived stressor is appraised
and which neuronal ensembles are recruited in the mPFC to ensure
various degrees of connectivity. This connectome underlies coping with
acute and chronic stressors congruent with domains of valence, emo-
tional expression, cognitive operation and psychosocial interaction
[118,119].
7. Concluding remarks
In this special issue, we present a survey showing that the number of
reports on application of the FST in phenotyping rodents is still
increasing. We note that the majority of the papers (about 72%) qua-
lifies the behavior of the floating rodent as depressive-like, but without
evidence for face, predictive or construct validity. We have asked a
selected group of 84 authors who use or have used the FST on how they
interpret behavioral performance of the rodents in their first and last
use of the FST: the majority of the responding authors (65,9%) rated
acquired immobility first as depressive-like behavior, while today this
number sharply declined to 12,2% favoring the interpretation of coping
strategy (56,1%) (Table 2).
This analysis is embedded in the current state-of-art in under-
standing the stress coping mechanism during the forced swim. Using
optogenetics and tracing techniques the top-down organization of the
stress coping circuitry is becoming rapidly understood. Neuronal en-
sembles in the mPFC area convey information downstream via hubs in
the stress connectome in a time- and context dependent manner leading
to the actual expression of active and passive coping strategy via dif-
ferent PAG columns. These hubs are also target for the glucocorticoid
stress hormones that has its MRs and GRs activated in a complementary
manner to modulate information processing from optimizing the coping
response to its memory storage for future use (Fig. 1).
The FST certainly is a powerful paradigm to examine the me-
chanism underlying coping with inescapable stressors. This includes the
study of the prefrontal-based coping circuit and glucocorticoid feedback
[120,59,63,58,121,122]. It also includes the inoculation of this coping
Box 3
Mineralocorticoid receptors (MRs) and Glucocorticoid receptors (GRs).
Glucocorticoids have an important function in management of stress-coping and behavioral adaptation. This action of glucocorticoids is
mediated in a complementary manner by MRs and GRs [90,29,91,92]. MRs are predominantly expressed in limbic-prefrontal neurons
[93,94,95,96] and their activation by naturally occurring glucocorticoids enhances excitability [97]. There are also aldosterone-selective
MR expressed in a discrete number of neurons in the n.tractus solitarii (NTS); this is because MRs are co-expressed in the NTS neurons with
an enzyme(11β-hydroxysteroid dehydrogenase type 2) that degrades cortisol and corticosterone [98].
GRs are co-localized with MRs and widely distributed with highest density in stress regulating centers such as the PVN, the limbic-
prefrontal cortical regions and the ascending aminergic neurons including the VTA-DA and striatal neurons [99,100,101]. The role of GRs is
to provide energy substrates for tissues in need and to protect against the body’s own initial defense reactions [102].
MRs and GRs occur as homodimers and heterodimers regulate gene transcription [103], but are also engaged in rapid non-genomic
actions. MR activation promotes excitatory transmission [104,106,97] and downregulates the mGLu receptor [107]. GR activation sup-
presses stress-induced activation, involving trans-synaptic endocannabinoid [108]. MR- and GR-mediated signaling needs to be in balance
for maintenance of homeostasis and health [109,111,29,92].
MR coping
Genomic
- Threshold/sensitivity of
the stress response system
- Immune activation
- Pro-inflammatory
Non-genomic
- Vigilance and attention
- Fear and aggression
- Appraisal
- Selection of coping style
MR/GR adaptation 
Genomic
- Negative feedback
- Contextualisation
- Rationalisation, motivation
- Metabolism
- Immune suppression
Non-genomic 
- Rapid glucocorticoid feed-
back  via the endocanna-
binoid receptor
GR memory 
Genomic
- Consolidation of memory
- Facilitation of extinction 
Non-genomic 
- Programming of brain circuitry in early
and peripubertal life
- Setpoint of stress response system
Fig. 1. MR, GR and stress coping. Flow diagram shows the
three different phases of glucocorticoid action mediated by
MR- and GR-mediated actions in the brain. MR activation af-
fects the initial appraisal process and the selection of coping
style. GR activation promotes behavioural adaptation and
memory storage. In appropriate contexts the memory trace is
retrieved again on demand via MR. Accordingly, MR- and GR-
mediated processes need to be in balance for homeostasis and
health. Data from [29,92,133,134].
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circuitry by life experiences that leave their mark on critical hubs in e.g.
the midbrain raphe nuclei [123] and in circuits that shift in time from
processing salient to executive brain functions [124,118]. The pro-
gramming effects involving epigenetics of the GR are best known
[7,125]. Early life effects on PAG-mediated panic behavior also have
been reported [126]. It is thought that resilience is favored if a later life
event matches the early life experience [127–129]. Upon a mismatch
between early and later life events vulnerability may increase, and re-
cent evidence suggests that such changes can be reset by anti-gluco-
corticoids [130–132]. Whether this glucocorticoid-susceptible match/
mismatch concept holds for inescapable stressors, such as tested in the
forced swim, remains to be examined.
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